Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...

Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

In the last three months, 11 analysts have published ratings on Confluent (NASDAQ:CFLT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...

Jan. 23, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S ...

Physical examination revealed a large, confluent, and bright red lichenified plaque with linear excoriations, small erosions, and scale covering the entire mons pubis, labia majora, medial thighs ...

Saami Khalifian, M.D., a double board-certified dermatologist based in Encinitas, CA, recommends those 35 and older add growth factor serum to their routine. “Around that age, collagen ...

After hours: February 3 at 5:24:49 PM EST Loading Chart for DERM ...

Vitiligo is an autoimmune skin disease characterized by melanocyte destruction. Regulatory T cells (Tregs) are greatly reduced in vitiligo skin, and replenishing peripheral skin Tregs can provide ...

Research breakthroughs are giving patients with atopic dermatitis/eczema more ways to treat this condition. See what a treatment plan may include.